BLFS Biolife Solutions Dashboard

BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Its products and services portfolio includes its proprietary CryoStor® freeze media, HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, and Custom Biogenic Systems high capacity storage freezers and SciSafe biologic storage services.

Company profile

Ticker

BLFS

Exchange

NASDAQ

Website

www.biolifesolutions.com

CEO

Michael Rice

Incorporated

Delaware

Location

Washington

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Electromedical & Electrotherapeutic Apparatus

Medtronic • Varian Medical Systems • Conmed • Natus Medical • Masimo • LivaNova • Outset Medical • Fonar • Cutera • Inmode ...

Former names

CRYOMEDICAL SCIENCES INC

SEC CIK

0000834365

Corporate docs

Articles of Incorporation & Bylaws

IRS number

943076866

BLFS stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data

13 Jul 21

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12)

Stocks That Hit 52-Week Highs On Monday

12 Jul 21

This morning 161 companies reached new 52-week highs.

The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO

9 Jul 21

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8)

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test

8 Jul 21

Looking Into BioLife Solutions's Return On Capital Employed

24 May 21

Press releases

Pro users get this 30m faster

BioVentrix Announces Raymond W. Cohen as Chairman of the Board and Newly Appointed Accredited Public Company Directors Rinda K. Sama and Andrew G. Hinson to Its Board of Directors

21 Jul 21

BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure via Transcatheter Ventricular Restoration (TCVR), today announced the appointment of Raymond W. Cohen as the

BioLife Solutions Announces Changes to Board of Directors

14 Jul 21

BOTHELL, Wash., July 14, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for

BioLife Solutions Adopts New Brand Identity

15 Jun 21

BOTHELL, Wash., June 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for

BioLife Solutions Announces First Quarter 2021 Financial Results

13 May 21

BioLife Solutions, Inc. to Host Earnings Call

13 May 21

Calendar

17 May 21

27 Jul 21

31 Dec 21

Financial summary

Financial statements Chart BLFS financial data

Quarter (USD)	Mar 21	Dec 20	Sep 20	Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	89M	89M	89M	89M	89M	89M
Cash burn (monthly)	466.67K	(positive/no burn)	372.67K	2.01M	(positive/no burn)	(positive/no burn)
Cash used (since last report)	1.81M	n/a	1.45M	7.81M	n/a	n/a
Cash remaining	87.19M	n/a	87.55M	81.19M	n/a	n/a
Runway (months of cash)	186.8	n/a	234.9	40.4	n/a	n/a

Beta Read what these cash burn values mean

Recent insider trades

BLFS insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
21 Jul 21	Aby J. Mathew	Common Stock	Sell	Dispose S	No	Yes	45.61	8,854	403.83K	209,589
21 Jul 21	Aby J. Mathew	Common Stock	Option exercise	Aquire M	No	No	1.64	8,854	14.52K	218,443
21 Jul 21	Aby J. Mathew	Employee Stock Option Common Stock	Option exercise	Dispose M	No	No	1.64	8,854	14.52K	98,853
20 Jul 21	Sarah Aebersold	Common Stock	Sell	Dispose S	No	No	45.1	1,059	47.76K	19,840
20 Jul 21	Marcus Schulz	Common Stock	Sell	Dispose S	No	No	45.1	2,539	114.51K	36,366
19 Jul 21	Aby J. Mathew	Common Stock	Sell	Dispose S	No	Yes	43.85	10,000	438.5K	209,589
19 Jul 21	Aby J. Mathew	Common Stock	Option exercise	Aquire M	No	No	1.64	10,000	16.4K	219,589
19 Jul 21	Aby J. Mathew	Employee Stock Option Common Stock	Option exercise	Dispose M	No	No	1.64	10,000	16.4K	107,707
16 Jul 21	Berard Todd	Common Stock	Sell	Dispose S	No	Yes	44.04	6,160	271.29K	79,064
16 Jul 21	Berard Todd	Common Stock	Option exercise	Aquire M	No	No	1.64	6,160	10.1K	85,224

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2021

BLFS institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

69.8% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	129	2	+6350.0%
Opened positions	127	1	+12600.0%
Closed positions	0	102	EXIT
Increased positions	0	1	EXIT
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	1.06B	326.29M	+225.0%
Total shares	28.17M	10.44M	+169.8%
Total puts	71.2K	0	NEW
Total calls	170K	0	NEW
Total put/call ratio	0.4	–	–

Largest owners	Shares	Value	Change
Casdin Capital	7.44M	$267.84M	0.0%
Villiger Walter	3M	$85.83M	0.0%
Vanguard	1.41M	$50.62M	NEW
BLK Blackrock	1.31M	$47.26M	NEW
Marshall Wace	1.18M	$42.34M	NEW
Wasatch Advisors	1.13M	$40.77M	NEW
Geneva Capital Management	1.03M	$37.19M	NEW
Ranger Investment Management	922.51K	$33.21M	NEW
AMP Ameriprise Financial	917.78K	$33.04M	NEW
Russell Investments	651.25K	$23.44M	NEW

Largest transactions	Shares	Bought/sold	Change
Vanguard	1.41M	+1.41M	NEW
BLK Blackrock	1.31M	+1.31M	NEW
Marshall Wace	1.18M	+1.18M	NEW
Wasatch Advisors	1.13M	+1.13M	NEW
Geneva Capital Management	1.03M	+1.03M	NEW
Ranger Investment Management	922.51K	+922.51K	NEW
AMP Ameriprise Financial	917.78K	+917.78K	NEW
Russell Investments	651.25K	+651.25K	NEW
BAC Bank Of America	527.33K	+527.33K	NEW
STT State Street	500.2K	+500.2K	NEW

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: administer, advanced, American, appointed, billed, Committee, constitute, consumer, criteria, de, decision, denominated, driven, Dusty, employed, Enhancing, ensure, environment, examine, exclusive, expansion, expedient, faced, foreign, Greef, grew, handling, healthcare, Hedging, hundred, hypothetical, inappropriate, indemnity, index, issuable, launch, leave, legislation, lessee, lessor, likelihood, machinery, maintenance, maker, margin, Maurice, Michael, milestone, moment, NaN, outlined, oversight, percent, preferred, premier, prepaid, primary, principal, ratably, regularly, reinforce, repayable, Rescue, response, retained, Retention, retrospective, revalued, Rice, Roderick, ROU, scenario, shipment, studying, Tenney, therewith, tied, transparency, unsatisfied, unsecured, USA, usage, valid

Removed: acceptable, acquire, adequate, adjusted, adjustment, administration, agree, aim, analyze, appraisal, attempt, avoidance, biopharmaceutical, book, borrowing, Casdin, CFR, classification, close, collateralized, computing, Conceptual, conform, continuously, Cryomedical, cryosurgical, cumulative, database, dating, delayed, Distinguishing, doubt, eligible, event, exceeding, existence, expecting, expire, fault, feasibility, focusing, forward, Framework, free, funded, generate, heightened, history, holdback, immaterial, implied, incentive, incorrectly, interpretation, landlord, lieu, LLC, located, marketer, medical, meeting, mentioned, merger, minute, mutually, notice, obligated, ordering, Origin, ownership, Password, privately, programming, promised, protected, provision, put, reached, reclassified, remeasured, requirement, requisite, restatement, reviewed, run, sample, satisfied, science, searchable, seller, shelf, sixty, subsequently, technological, terminate, thaw, Trump, uncertainty, unlimited, Vice

From filing 10-Q 2021 Q1